Free Trial
Dan Brennan

Dan Brennan Analyst Performance

Senior Equity Research Analyst - Managing Director at TD Cowen

Dan Brennan is a stock analyst at TD Cowen focused in the medical sector, covering 23 publicly traded companies. Over the past year, Dan Brennan has issued 37 stock ratings, including buy and hold recommendations. While full access to Dan Brennan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Dan Brennan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
43 Last 4 Years
Buy Recommendations
61.90% 26 Buy Ratings
Companies Covered
23 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy61.9%26 ratings
Hold38.1%16 ratings
Sell0.0%0 ratings

Out of 42 total stock ratings issued by Dan Brennan at TD Cowen, the majority (61.9%) have been Buy recommendations, followed by 38.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
69.6% of companies on NASDAQ
16 companies
NYSE
30.4% of companies on NYSE
7 companies

Dan Brennan, an analyst at TD Cowen, currently covers 23 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
21 companies
91.3%
Manufacturing
1 company
4.3%
Computer and Technology
1 company
4.3%

Dan Brennan of TD Cowen specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
8 companies
34.8%
MED PRODUCTS
4 companies
17.4%
MEDICAL SERVICES
4 companies
17.4%
MEDICAL INFO SYS
3 companies
13.0%
MED INSTRUMENTS
2 companies
8.7%
LAB ANALYTICAL INSTRUMENTS
1 company
4.3%
INSTRU - SCIENTFC
1 company
4.3%

About Dan Brennan

At TD Cowen, Dan is responsible for providing research coverage on a diverse group of companies across the Life Science & Diagnostics Tools’ industry. This includes identifying key investment debates, building financial models, generating research reports, including ‘Ahead of the Curve’ deep dive analysis, making stock recommendations and engaging with clients and TD Cowen representatives. Daniel Brennan is a senior analyst covering Life Science & Diagnostic Tools. Prior to joining TD Cowen, Dan was a Managing Director and senior Life Science & Diagnostic Tools analyst at UBS. Prior to UBS, he was a senior health care analyst at Columbus Circle Investors. Dan also spent 19 years at Morgan Stanley, where he served, amongst other roles, as the health care sector equity sales specialist and later as the senior Life Science & Diagnostic Tools analyst. Mr. Brennan holds a BA in economics from Georgetown University, and an MBA from Harvard University. He is also a CFA® charterholder.
Follow on LinkedIn

Dan Brennan's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Qiagen N.V. stock logo
QGEN
Qiagen
5/7/2026Reiterated Rating$33.72$40.00Hold
Quanterix Corporation stock logo
QTRX
Quanterix
5/7/2026Lower Price Target$2.72$4.00Hold
Waters Corporation stock logo
WAT
Waters
5/6/2026Boost Price Target$352.53$385.00Hold
GRAIL, Inc. stock logo
GRAL
GRAIL
5/6/2026Boost Price Target$55.73$69.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
5/6/2026Boost Price Target$13.44$21.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
5/6/2026Boost Price Target$54.07$68.00Buy
Revvity Inc. stock logo
RVTY
Revvity
5/6/2026Boost Price Target$99.54$120.00Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
4/29/2026Boost Price Target$8.35$14.00Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
3/16/2026Reiterated Rating$8.22Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2/26/2026Lower Price Target$115.34$157.00Buy
Exagen Inc. stock logo
XGN
Exagen
2/24/2026Lower Price Target$3.82$10.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
2/20/2026Boost Price Target$106.35$135.00Buy
10x Genomics stock logo
TXG
10x Genomics
2/13/2026Boost Price Target$19.27$19.00Hold
Bruker Corporation stock logo
BRKR
Bruker
2/13/2026Lower Price Target$37.12$43.00Hold
Avantor, Inc. stock logo
AVTR
Avantor
2/12/2026Reiterated Rating$9.66Hold
Revvity Inc. stock logo
RVTY
Revvity
2/3/2026Reiterated Rating$105.76Hold
Revvity Inc. stock logo
RVTY
Revvity
2/3/2026Boost Price Target$108.03$124.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
1/30/2026Lower Price Target$576.73$683.00Buy
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
1/7/2026Boost Price Target$618.81$696.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
1/7/2026Boost Price Target$149.46$140.00Hold
Danaher Corporation stock logo
DHR
Danaher
1/7/2026Boost Price Target$233.76$270.00Buy
Bruker Corporation stock logo
BRKR
Bruker
1/7/2026Boost Price Target$52.38$53.00Hold
10x Genomics stock logo
TXG
10x Genomics
1/7/2026Boost Price Target$19.71$18.00Hold
Avantor, Inc. stock logo
AVTR
Avantor
1/7/2026Lower Price Target$12.09$12.00Hold
MDxHealth SA stock logo
MDXH
MDxHealth
11/13/2025Boost Price Target$4.04$7.00Buy
Waters Corporation stock logo
WAT
Waters
11/5/2025Boost Price Target$372.56$390.00Hold
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
11/4/2025Boost Price Target$68.93$90.00Buy
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
11/4/2025Boost Price Target$6.50$9.00Hold
Bruker Corporation stock logo
BRKR
Bruker
11/4/2025Boost Price Target$39.95$42.00Hold
Illumina, Inc. stock logo
ILMN
Illumina
10/31/2025Boost Price Target$121.42$115.00Hold
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/23/2025Boost Price Target$564.73$654.00Buy
Danaher Corporation stock logo
DHR
Danaher
10/22/2025Boost Price Target$219.03$260.00Buy
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
10/14/2025Boost Price Target$138.43$162.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/25/2025Boost Price Target$60.60$72.00Buy
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
9/12/2025Boost Price Target$8.24$12.00Buy
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
8/6/2025Boost Price Target$11.54$15.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
5/1/2025Boost Price Target$48.06$60.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
5/1/2025Lower Price Target$64.88$110.00Buy
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
3/21/2025Lower Price Target$2.31$2.50Neutral
Tempus AI, Inc. stock logo
TEM
Tempus AI
2/5/2025Reiterated Rating$61.85$74.00Buy